USPTO Archives | Be Korea-savvy
Samsung Electronics Wins Patents for Drones in U.S.

Samsung Electronics Wins Patents for Drones in U.S.

SEOUL, Mar. 30 (Korea Bizwire) — Samsung Electronics Co. registered two patents related to drones with the United States Patent and Trademark Office (USPTO) this month, industry sources said Friday, a sign that the South Korean tech giant may move into the segment in the near future. According to sources, Samsung won patents related to [...]

Pantech Transferred 230 U.S. Intellectual Property Rights to Patent Control Entity

Pantech Transferred 230 U.S. Intellectual Property Rights to Patent Control Entity

SEOUL, May 22 (Korea Bizwire) — Pantech Co. South Korea’s smallest smartphone manufacturer that recently announced it will suspend production of mobile devices, turned over 230 U.S. patents to another company, official data showed Sunday. Information provided by the United States Patent and Trademark Office (USPTO) showed that Patech, owned by Solid Inc. a local [...]

RedHill Biopharma Receives Notice of Allowance for Two Additional U.S. Patents Covering BEKINDA®

RedHill Biopharma Receives Notice of Allowance for Two Additional U.S. Patents Covering BEKINDA®

TEL-AVIV, Israel, Apr. 18 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced that it has received notices of allowance from the [...]

RedHill Biopharma Receives Additional U.S. Patent Covering RHB-105 Ahead of Confirmatory Phase III Study for H. pylori Infection

TEL-AVIV, Israel, Jul. 21 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for inflammatory and gastrointestinal diseases and cancer, today announced that it has received a Notice of Allowance from the United States Patent [...]